PureTech Health PLC (PRTC.LN) said Tuesday that affiliate company Entrega will receive $5 million after entering a research-collaboration agreement with Eli Lilly & Co. (LLY).
Entrega will receive the sum in equity and research funding from Eli Lilly, allowing it to investigate the application of its peptide-delivery technology to Eli Lilly products and therapeutic candidates, PureTech said.
Continue Reading Below
The agreement does not grant Eli Lilly a development or commercialization license for the Entrega technology, PureTech added.
Shares in PureTech Health at 0949 GMT were up 4%, or 5 pence, at 145.00 pence.
Write to Oliver Griffin at firstname.lastname@example.org
(END) Dow Jones Newswires
December 19, 2017 05:15 ET (10:15 GMT)